Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant

Philip G Ferstl1, Natalie Filmann2, Eva-Maria Heilgenthal1

  • 1Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.

Plos One
|January 22, 2021
PubMed
Abstract

Insights

Multidrug-resistant organism (MDRO) colonization increases mortality risk for liver transplant candidates on the waiting list. However, MDRO colonization did not significantly impact short-term survival post-liver transplant, though carbapenem-resistant gram-negative bacteria pose a high risk.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Rising prevalence of multidrug-resistant organisms (MDRO) presents a significant challenge in patients with liver cirrhosis.
  • The specific impact of MDRO colonization on mortality in liver transplantation (LT) candidates and recipients requires detailed investigation.

Purpose of the Study:

  • To determine the impact of MDRO colonization on mortality in liver transplant candidates and recipients.
  • To analyze the incidence and outcomes of MDRO colonization during the LT waiting period and post-transplant.

Main Methods:

  • Screening for MDRO colonization (MRSA, MDRGN, VRE) in 351 LT candidates from 2008-2018.
  • Monitoring colonization status at LT evaluation, during hospitalizations, and post-transplant.
  • Analyzing mortality rates associated with MDRO colonization.

Main Results:

  • MDRO colonization incidence increased during the LT waiting time.
  • MDRO colonization was significantly associated with increased mortality on the waiting list (HR = 2.57, p<0.0001).
  • Colonization with carbapenem-resistant gram-negative bacteria (CRGN) was associated with high mortality in 10 out of 14 affected patients.

Conclusions:

  • MDRO colonization is linked to higher mortality risk for patients awaiting liver transplantation.
  • Short-term survival after liver transplant is not significantly affected by MDRO colonization.
  • Carbapenem-resistant gram-negative bacteria colonization appears to be a critical factor for high mortality in liver transplant candidates and recipients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
155
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
720
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
507
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
104
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
639
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
151